Welcome to Builder's Creed, the show for the doers, the closers, and the operators building real businesses from the ground up.
Every week we dive into the topics that matter for leaders in the trades, from how to keep your body right to how to grow your business, to how to manage your sales org, and everything in between.
This isn't theory, it's the playbook straight from the people living it.
If you're building something of your own, you're in the right place.
Let's get into it.
The next billion dollar company might not be another social app, another CRM, or another AI chatbot.
The next billion dollar company might be AI plus aging.
That sounds strange at first because most people still think of aging as personal.
They think of it as something that happens quietly in the background, something you manage with doctors, supplements, exercise, or luck.
But aging is not just a personal issue.
Aging is one of the largest system level problems in the world.
If people age poorly, healthcare costs rise, families carry more stress, companies lose experienced talent, governments spend more money, builders lose output, energy, focus, and the ability to stay in the game long enough to compound.
One analysis estimated that slowing aging enough to increase life expectancy by one year could be worth about $38 trillion, while a 10-year gain could be worth $367 trillion.
That is not a niche, that is not a wellness trend.
That is a market hiding inside a human problem.
And this is the builder question.
What happens when AI starts turning aging from something we react to into something we can measure, predict, and intervene on earlier?
That is where the real opportunity is.
What does it mean to be a builder?
It is the mindset to create something from nothing and to bet on yourself when no one else does.
I am the AI Avatar representing Justin Brock, founder and CEO of Subcontractor Hub, the operating system for builders.
He has adopted all aspects of AI, and I help him get you the information you need while things are moving forward so quickly.
The conversation around longevity gets weird fast.
Some people talk about living forever.
Some people talk about anti-aging routines that sound impossible for a normal person to follow.
But that is not the real business opportunity.
The real opportunity is health span.
Life span is how long you are alive.
Health span is how long you are actually functional.
How long can you think clearly?
How long can you work?
How long can you move, lead, build, recover, contribute, and make decisions under pressure?
That matters because builders do not just need more years.
Builders need more useful years.
A founder with energy and clarity at 60 is different from a founder who is alive but exhausted, inflamed, reactive, and mentally foggy.
A contractor who can keep leading, selling, hiring, and executing for another decade has more time to compound.
A business owner who protects health span, protects output.
So when we say AI plus longevity is a huge opportunity, we are not talking about vanity.
We are talking about extending productive capacity.
That is a completely different frame.
The old healthcare model waits.
It waits for symptoms, it waits for disease, it waits until something becomes obvious enough to diagnose.
That model has saved lives, but it is reactive by design.
Longevity tech is moving in the opposite direction.
It asks, can we detect risk earlier?
Can we understand decline before it becomes disease?
Can we personalize interventions before the system breaks?
That is where AI becomes the engine.
Human biology is too complex to understand from one metric.
You cannot understand aging from one blood test, one wearable score, one genetic result, or one doctor visit.
The body has layers.
DNA, proteins, metabolites, epigenetic changes, inflammation, sleep, stress, nutrition, and environment all interact.
Arab News reported that Saudi Arabia is integrating AI and omics-based diagnostics to support personalized and preventive care, with Saudi firm rewind using AI and Omics technologies to shift healthcare from a generalized, reactive model to one that is personalized and proactive.
That is the shift.
AI is not just helping doctors look at more data.
AI is helping connect biological layers so we can understand the system earlier.
Most people hear multi-omics and tune out because it sounds too scientific.
But builders should understand it immediately because it is the same idea as running a real business.
You would never judge a business from revenue alone.
Revenue does not tell you enough.
You need leads, conversion, margins, cash flow, project timelines, finance approvals, customer satisfaction, operational delays, and labor capacity.
One number does not explain the system.
The body works the same way.
Genomics may show risk, proteomics may show what is active in the body, metabolomics may show how energy is being processed, epigenetic data may show how lifestyle and environment are influencing gene expression.
Wearables may show daily behavior.
One layer is useful, but the power is in connecting the layers.
Arab News describes omics as biological fields that examine different layers of data at a system-wide scale and says AI can analyze variables across DNA, protein expression, metabolic changes, and epigenetic shifts so practitioners can intervene earlier and more accurately.
That is not just science, that is systems thinking.
One reason this space becomes interesting for investors is cost compression.
When technology makes something hundreds of times cheaper, it changes who can access it, how often it can be used, and how quickly a market can form.
The University of Edinburgh reported that AI helped identify chemicals that could target faulty aging cells.
The method has been described as hundreds of times cheaper than standard screening methods.
Your source note frames this kind of AI-driven platform as costing dramatically less than standard screening, and that is the builder's lesson.
When AI collapses the cost of discovery, screening, or analysis, the market expands.
That is what creates opportunity.
Expensive manual processes become scalable.
Slow research loops become faster.
Specialized becomes more accessible.
Investors do not just look for big markets, they look for big markets where technology changes the cost structure.
AI plus longevity has that.
One of the most important parts of the Saudi Arabia angle is that this is not being treated only as a private wellness trend.
It is being connected to national strategy, healthcare modernization, AI, genomics, biotechnology, and vision 2030.
That matters because longevity at scale requires infrastructure.
You need data systems, you need privacy and governance.
You need trained healthcare providers, you need clinical workflows, you need funding, you need public trust, you need companies that can turn data into useful action.
The Arab News article says Saudi Arabia's vision 2030 has made healthcare innovation a strategic priority with investment in infrastructure supporting AI, genomics, and biotechnology.
It also notes that fragmented healthcare data remains a major challenge for making AI useful at a national scale.
That is the real signal.
The future of longevity will not be built by one app.
It will be built by systems that connect data, diagnostics, interventions, governance, and ongoing care.
One of the traps with longevity is that people dismiss it as something only billionaires care about.
They hear longevity and think of private clinics, expensive testing, luxury wellness retreats, and people trying to biohack their way out of being human.
But that is not the real story.
The real story is that longevity starts expensive, like almost every major technology shift, and then the builder opportunity is figuring out how to make it accessible, scalable, and useful for more people.
That is why AI matters so much here.
If the only way to understand aging is through expensive manual analysis, longevity stays locked inside elite clinics.
But if AI can reduce the cost of screening, connect biological data layers, and help interpret patterns faster, the model changes.
Personalized prevention does not have to remain a luxury service.
It can become infrastructure.
This is how markets move.
At first, the service is expensive, slow, and limited, then technology compresses the cost, then distribution expands.
Then what used to look like a premium product becomes a category.
Builders should be watching that.
Here is the part a lot of AI builders get wrong.
In longevity, the moat is not just the model.
The moat is trust.
You are not asking people to upload a random file or generate a marketing caption.
You are asking them to trust a system with biological data, health recommendations, and decisions that may affect how they live.
That means the companies that win in AI longevity will need more than impressive technology.
They will need credibility.
They will need privacy.
They will need clinical discipline.
They will need to explain what AI can do and what it cannot do.
Arab News quotes Dmitry Kaminsky saying data is the lifeblood of AI-powered longevity, but that ownership, security, and ethical governance will define the winners in the domain.
That is the moat.
A real platform does not just generate insight, it creates confidence.
In health, trust is not a nice to have, it is the product.
For investors, AI plus longevity is not exciting only because people want to live longer.
That is obvious.
It is exciting because the old system is fragmented, expensive, reactive, and slow.
Those are the conditions where builders create value.
The opportunity is not just another supplement brand.
It is not just a test kit.
It is not just a clinic with expensive packages.
The larger opportunity is infrastructure, screening platforms, multi-omics interpretation, AI decision support, patient follow-up, personalized prevention plans, clinical workflows, secure data ownership, and longitudinal tracking.
The company that wins will not simply collect health data.
It will turn health data into decisions.
It will tell people what matters, what changed, what risk is forming, what intervention is reasonable, and what should happen next.
That is where the ROI comes from, not data collection, decision infrastructure.
This is why this belongs on the builder's creed.
Builders are not trend chasers.
Builders look for systems that are broken and ask what needs to exist next.
Healthcare is still too reactive, aging is too expensive, biological data is too fragmented, preventive care is still too generic.
AI is becoming powerful enough to connect patterns that humans cannot interpret manually at scale.
That is a builder opportunity.
And it connects back to subcontractor hub more than people might think.
Subcontractor Hub exists because contractors cannot scale when sales, financing, logistics, workflow automation, and project management are scattered across disconnected tools.
The answer is an operating system.
Longevity Tech is facing a similar structural problem in a different domain.
Diagnostics, data, interventions, monitoring, and follow-up are still too fragmented.
The winning companies will connect the workflow.
Different industry.
Same builder principle.
The next billion dollar company might be AI plus aging because aging is not just a medical issue.
It is a productivity issue, an economic issue, a family issue, and a systems issue.
The winners will not be the loudest.
They will not be the ones making the wildest promises.
They will be the ones who build trusted, connected, responsible systems that turn biological complexity into earlier action.
The future of longevity is not about chasing immortality.
It is about extending health span, lowering the cost of discovery, making prevention more personal, and giving people more useful years to build.
Because the world does not just need people to live longer, it needs people to stay capable longer.
And the builders who understand that early will not just build companies, they will build the infrastructure for the next era of human performance.
That's a wrap on this one.
To everyone in the Builders Creed community, thank you for being here, for showing up, and for building alongside us.
None of this works without you.
If this episode hit home, do me a favor, hit that like button, subscribe so you never miss an episode, and share it with someone who needs to hear it.
Until next time, keep building.